BACKGROUND: Myofascial Pain Syndrome causes disability in daily life activities and despite all efforts, it continues to be a challenge, perpetuating suffering, overloading services and costs. New treatment options need to be tested. OBJECTIVE: We aimed to quantify the rESWT short-term analgesic effect and identify the success predictors through results comparisons achieved in MPS and Articular Pain (AP). METHOD: Retrospective cohort study of 1,580 patients with Myofascial Pain Syndrome or Articular Pain underwent two weekly radial Extracorporeal Shock-wave Therapy sessions. The pain intensity was measured by Visual Analog Scale before and one week after the end of the treatment (3 weeks). RESULTS: The therapy decreases pain by 62.50% (p< 0.0001), with a high success rate (91.59%) and a low worsening rate (2.1%). The best recommendation is for patients with intense myofascial pain (Visual Analog Scale ⩾ 70 mm), using high shock-wave frequency (⩾ 15 Hz). CONCLUSIONS: Two rESWT sessions promote pain relief, with a high success rate and low rates of treatment abandonment and worsening. The best results are obtained in myofascial pain patients with high pain intensity, treated with high-frequency dosage.
The aim of the present study was to quantitatively analyze the response of patients with chronic low back pain to treatment at the Back School at the IMREA-HCFMUSP. The following scales were used to measure the therapeutic response: the Oswestry Low Back Pain Disability Questionnaire, a Visual Analog Scale (VAS), and a corporal diagram of the pain. The sample was composed of 43 patients with chronic low back pain evaluated, treated, and referred to by the Back School program. The results showed significant improvement among those who completed the program in all three scales applied. Since the period of study was only two months, the results do not support any claim that the Back School is also this effective on long-term treatment of chronic low back pain. Further qualitative and quantitative studies must be carried out in order to support the development of specialized multi-professional teams, who will carry out alterations and improvements in therapeutic resources to the management of chronic low back pain.
Background: Musculoskeletal pain is a quite common, benign, nonfatal condition that is the second leading cause of years lived with a disability worldwide. Despite all efforts, it continues to be a challenging public health problem, because the solutions currently available are complex or are of limited effectiveness, which makes them difficult to adopt. That situation perpetuates suffering and treatment seeking, as well as increasing the health care costs and burden associated with such pain. Therefore, new treatment options need to be tested and the interest in shock waves is growing, especially in places with few resources, with difficult access to medications and in countries where there is a need for new therapeutic options due to the opioid crisis.Methods: This was a retrospective observational study of 1,580 patients with musculoskeletal pain who underwent two weekly sessions of radial extracorporeal shock-wave therapy.Results: We found that the therapy tested decreased pain by 62.50% (P < 0.0001), with a high (91.59%) success rate and a low (2.1%) rate of pain worsening (2.1%). The effect was greatest for myofascial pain in the hip or shoulder (P < 0.05). Intense pain, myofascial pain (visual analogue scale score ≥ 70 mm), and high shock-wave frequency (≥ 15 Hz) correlated with best response. Conclusions: It is possible to implement a radial shockwave service that, with just two doses, promotes rapid and effective analgesia for up to 7 days after the last dose, with a high success rate and a low rate of abandonment of treatment. Representing a response to the management of service overload and a non-drug alternative in the era of the opioid crisis.Study registration: CAAE 51289115.2.0000.5463. Registered 7th October 2015 (prospectively registered).
Alguns artigos científicos já demonstraram a importância da iniciação cientifica durante a graduação e suas repercussões na vida profissional do futuro médico: os jovens formados se tornam melhores médicos pois adquirem um espírito crítico, capacidade de selecionar informações relevantes durante o vertiginoso processo de atualização médica, transformando-se até mesmo em líderes regionais. Carlos da Silva Lacaz, aluno de graduação, presidente do Departamento Científico do Centro Acadêmico Oswaldo Cruz e, mais tarde, grande médico, pesquisador e diretor da Faculdade de Medicina da USP promoveu pela primeira vez, em outubro de 1940, o Congresso dos Estudantes de Medicina, que mais tarde seria o nosso Congresso Médico Universitário (COMU). O Congresso surgiu da necessidade de se premiar e estimular a produção científica feita pelos acadêmicos. São as palavras de Carlos da Silva Lacaz em um jornal da época: (...) procuramos estimular a nós mesmos. Eles (os congressos) são um complemento necessário à teoria e à prática do ensino, pois proporcionam uma oportunidade a mais para confrontar pesquisas e estudos especializados. Na época houve cerca de 89 trabalhos científicos a serem julgados e premiados pelos professores. Assim, valorizando o Congresso estamos direta e indiretamente valorizando a formação do futuro profissional e da ciência médica no Brasil. O Departamento Científico agradece a todos os Professores que, de alguma forma, nos ajudam a realizar esse grande projeto.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.